A multi-country clinical trial has delivered the strongest evidence yet that a structured programme of diet, exercise, cognitive training and vascular monitoring can slow cognitive decline in older adults. The LatAm-FINGERS study, which followed more than 1,000 participants across 11 Latin American countries including Argentina, found that those receiving supervised interventions improved their cognitive scores 55% more than a control group given only general health advice. The results, presented in London on 13 July 2026 and published simultaneously in The Lancet, extend findings from earlier Finnish and US trials into a region where public health systems face distinct resource constraints.

While the trial reinforces the value of multi-domain lifestyle changes, a separate observational study of nearly 13,000 adults, led by researchers at the University of São Paulo, complicates the dietary picture. It found that the highest consumers of sweeteners such as aspartame, saccharin and erythritol experienced a 62% faster rate of cognitive decline than the lowest consumers; even moderate intake was associated with a 35% acceleration. The effect was particularly pronounced among participants with diabetes. The findings, published by the American Academy of Neurology, do not establish causation but add to a growing body of evidence that not all sugar replacements are metabolically or neurologically neutral.

A review from Semmelweis University in Budapest, published in Nutrients, examined hundreds of studies on polyphenols—compounds found in berries, tea, olive oil and cocoa—and concluded that their antioxidant and anti-inflammatory properties may support neuronal function. The authors cautioned, however, that the evidence is not yet sufficient to recommend any single food or supplement for dementia prevention, pointing instead to the overall dietary patterns of the Mediterranean and MIND diets. Meanwhile, neurologists in India, marking World Brain Day, warned that chronic sleep deprivation and excessive screen exposure are undermining brain health. They described a vicious cycle in which evening screen use suppresses melatonin, disrupts sleep architecture and impairs the brain’s overnight clearance of metabolic waste, with clinicians reporting a rise in patients presenting with memory lapses and poor concentration.

The convergence of trial data and observational studies is shifting the focus from general wellness advice toward structured, supervised interventions. The next milestone to watch is whether health authorities in Latin America and beyond move to integrate such programmes into standard preventive care, and whether food safety agencies re-examine sweetener guidelines in light of the cognitive findings.